The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to ...

We've heard how the use of drugs like Ozempic can drive weight loss, as well as potentially boost heart health and cut out ...

The beauty industry is on the cusp of significant change where design will overthrow genetics. Vogue Business explores the ...

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

A new study led by researchers at the Arkansas Agricultural Experiment Station has found that the popular class of weight-loss drugs known as GLP-1 agonists—including Mounjaro, Ozempic, and Wegovy—is ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

For the past few years, the buzz around drugs termed rather technically GLP-1 agonists has been deafening. That stands for glucagon-like peptide 1 receptor agonists, so we trust you won’t mind the ...

What is peptide therapy to boost athletic performance and speed up recovery time? Here's what the science shows about whether ...

Ozempic has become one of the most talked-about topics in the showbiz world. Time and again, this name pops up on social ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.